{"id":8661,"date":"2025-09-18T00:36:20","date_gmt":"2025-09-17T21:36:20","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=8661"},"modified":"2025-09-18T00:36:20","modified_gmt":"2025-09-17T21:36:20","slug":"acc-guidance-vaccination-in-cardiovascular-disease","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/acc-guidance-vaccination-in-cardiovascular-disease\/","title":{"rendered":"ACC Guidance: Vaccination in Cardiovascular Disease"},"content":{"rendered":"<div>ACC Guidance: Vaccination in Cardiovascular Disease<\/div>\n<div><\/div>\n<div>Source: Journal of the American College of Cardiology (JACC) \u2013 August 28, 2025<\/div>\n<div><span> 1. Core Recommendation<\/span><\/div>\n<div><span> \u2022 Adults with cardiovascular disease (CVD) should receive vaccines against:<\/span><\/div>\n<div>* Influenza<\/div>\n<div>* COVID-19<\/div>\n<div>* Respiratory syncytial virus (RSV)<\/div>\n<div><span> \u2022 Other vaccines (pneumococcal, shingles) may also provide cardiovascular protection.<\/span><\/div>\n<div><span> 2. Rationale<\/span><\/div>\n<div><span> \u2022 Respiratory illness increases cardiac workload, leading to dyspnea, chest pain, hospitalization, or death.<\/span><\/div>\n<div><span> \u2022 Vaccination may not prevent infection but reduces severity and complications.<\/span><\/div>\n<div><span> 3. Evidence &amp; Endorsements<\/span><\/div>\n<div><span> \u2022 ESC (2025 consensus): Vaccination should be considered the \u201cfourth pillar\u201d of CVD prevention (after antihypertensives, lipid-lowering drugs, and diabetes meds).<\/span><\/div>\n<div><span> \u2022 Data:<\/span><\/div>\n<div>* 5% rise in flu activity \u2192 24% rise in HF hospitalizations.<\/div>\n<div>* COVID-19 strongly linked to new\/worsened CVD.<\/div>\n<div>* RSV, parainfluenza, adenovirus, pneumococcal infections increase CVD morbidity and mortality.<\/div>\n<div><span> 4. Vaccine Uptake (US Data)<\/span><\/div>\n<div><span> \u2022 &lt; 50% adults vaccinated for influenza (2024).<\/span><\/div>\n<div><span> \u2022 &lt; 25% for COVID-19 and RSV vaccines.<\/span><\/div>\n<div><span> \u2022 FDA (Aug 2025): New updated COVID-19 vaccines approved, with priority for high-risk groups such as CVD patients.<\/span><\/div>\n<div><span> 5. Barriers to Vaccination<\/span><\/div>\n<div><span> \u2022 Patient unawareness of link between heart disease and infection risks.<\/span><\/div>\n<div><span> \u2022 Specialty clinics not structured to provide vaccines.<\/span><\/div>\n<div><span> \u2022 Copays and access issues may deter patients.<\/span><\/div>\n<div><span> 6. Supporting Data (AHA Research)<\/span><\/div>\n<div><span> \u2022 ~20% of adults hospitalized with RSV had MI or HF.<\/span><\/div>\n<div><span> \u2022 COVID-19 \u2192 higher risk of HF, arrhythmia, CAD.<\/span><\/div>\n<div><span> \u2022 Risk of MI \u2191 sixfold in the week after influenza.<\/span><\/div>\n<div><span> 7. Practical Guidance<\/span><\/div>\n<div><span> \u2022 Cardiologists should use clinic visits to educate and recommend vaccination.<\/span><\/div>\n<div><span> \u2022 Health plans still required to cover many vaccines at no charge.<\/span><\/div>\n<div><\/div>\n<div><a href=\"https:\/\/esc365.escardio.org\/session\/42952\">https:\/\/esc365.escardio.org\/session\/42952<\/a><\/div>\n<div><\/div>\n<div><a href=\"https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2025\/08\/26\/11\/47\/sun-influenza-rsv-esc-2025?utm_source=chatgpt.com\">https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2025\/08\/26\/11\/47\/sun-influenza-rsv-esc-2025?utm_source=chatgpt.com<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ACC Guidance: Vaccination in Cardiovascular Disease Source: Journal of the American College of Cardiology (JACC) \u2013 August 28, 2025 1. Core Recommendation \u2022 Adults with cardiovascular disease (CVD) should receive vaccines against: * Influenza * COVID-19 * Respiratory syncytial virus (RSV) \u2022 Other vaccines (pneumococcal, shingles) may also provide cardiovascular protection. 2. Rationale \u2022 Respiratory [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8661","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=8661"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8661\/revisions"}],"predecessor-version":[{"id":8662,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8661\/revisions\/8662"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=8661"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=8661"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=8661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}